Regional microglial activation in the substantia nigra is linked with fatigue in MS
- PMID: 32769103
- PMCID: PMC7643614
- DOI: 10.1212/NXI.0000000000000854
Regional microglial activation in the substantia nigra is linked with fatigue in MS
Abstract
Objective: The goal of our study is to assess the role of microglial activation in MS-associated fatigue (MSAF) using [F-18]PBR06-PET.
Methods: Fatigue severity was measured using the Modified Fatigue Impact Scale (MFIS) in 12 subjects with MS (7 relapsing-remitting and 5 secondary progressive) and 10 healthy control participants who underwent [F-18]PBR06-PET. The MFIS provides a total fatigue score as well as physical, cognitive, and psychosocial fatigue subscale scores. Standardized Uptake Value (SUV) 60-90 minute frame PET maps were coregistered to 3T MRI. Voxel-by-voxel analysis using Statistical Parametric Mapping and atlas-based regional analyses were performed. SUV ratios (SUVRs) were global brain normalized.
Results: Peak voxel-based level of significance for correlation between total fatigue score and PET uptake was localized to the right substantia nigra (T-score 4.67, p = 0.001). Similarly, SUVRs derived from atlas-based segmentation of the substantia nigra showed significant correlation with MFIS (r = 0.76, p = 0.004). On multiple regression, the right substantia nigra was an independent predictor of total MFIS (p = 0.02) and cognitive MFIS subscale values (p = 0.007), after adjustment for age, disability, and depression. Several additional areas of significant correlations with fatigue scores were identified, including the right parahippocampal gyrus, right precuneus, and juxtacortical white matter (all p < 0.05). There was no correlation between fatigue scores and brain atrophy and lesion load in patients with MS.
Conclusion: Substantia nigra microglial activation is linked to fatigue in MS. Microglial activation across key brain regions may represent a unifying mechanism for MSAF, and further evaluation of neuroimmunologic basis of MSAF is warranted.
Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
Figures
Similar articles
-
Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study.Neurol Neuroimmunol Neuroinflamm. 2019 Jul 1;6(5):e587. doi: 10.1212/NXI.0000000000000587. eCollection 2019 Sep. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 31355321 Free PMC article.
-
18F-PBR06 Versus 11C-PBR28 PET for Assessing White Matter Translocator Protein Binding in Multiple Sclerosis.Clin Nucl Med. 2018 Sep;43(9):e289-e295. doi: 10.1097/RLU.0000000000002179. Clin Nucl Med. 2018. PMID: 30004939
-
Resting-state functional connectivity networks associated with fatigue in multiple sclerosis with early age onset.Mult Scler Relat Disord. 2019 Jun;31:101-105. doi: 10.1016/j.msard.2019.03.020. Epub 2019 Mar 30. Mult Scler Relat Disord. 2019. PMID: 30954931
-
Longitudinal associations between brain structural changes and fatigue in early MS.Mult Scler Relat Disord. 2016 Jan;5:29-33. doi: 10.1016/j.msard.2015.10.006. Epub 2015 Oct 21. Mult Scler Relat Disord. 2016. PMID: 26856940
-
Evaluation of MS related central fatigue using MR neuroimaging methods: Scoping review.J Neurol Sci. 2019 May 15;400:52-71. doi: 10.1016/j.jns.2019.03.007. Epub 2019 Mar 14. J Neurol Sci. 2019. PMID: 30903860 Review.
Cited by
-
The development status of PET radiotracers for evaluating neuroinflammation.Nucl Med Mol Imaging. 2024 Jun;58(4):160-176. doi: 10.1007/s13139-023-00831-4. Epub 2024 Jan 8. Nucl Med Mol Imaging. 2024. PMID: 38932754 Free PMC article. Review.
-
Patient-reported outcome parameters and disability worsening in progressive multiple sclerosis.Mult Scler Relat Disord. 2024 Jan;81:105139. doi: 10.1016/j.msard.2023.105139. Epub 2023 Nov 18. Mult Scler Relat Disord. 2024. PMID: 38000130
-
CSF Markers of Oxidative Stress Are Associated with Brain Atrophy and Iron Accumulation in a 2-Year Longitudinal Cohort of Early MS.Int J Mol Sci. 2023 Jun 12;24(12):10048. doi: 10.3390/ijms241210048. Int J Mol Sci. 2023. PMID: 37373196 Free PMC article.
-
Beyond the symptom: the biology of fatigue.Sleep. 2023 Sep 8;46(9):zsad069. doi: 10.1093/sleep/zsad069. Sleep. 2023. PMID: 37224457 Free PMC article. Review.
-
18F-Radiolabeled Translocator Protein (TSPO) PET Tracers: Recent Development of TSPO Radioligands and Their Application to PET Study.Pharmaceutics. 2022 Nov 21;14(11):2545. doi: 10.3390/pharmaceutics14112545. Pharmaceutics. 2022. PMID: 36432736 Free PMC article. Review.
References
-
- Calabrese M, Rinaldi F, Grossi P, et al. . Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing-remitting multiple sclerosis. Mult Scler 2010;16:1220–1228. - PubMed
-
- Comi G, Leocani L, Rossi P, Colombo B. Physiopathology and treatment of fatigue in multiple sclerosis. J Neurol 2001;248:174–179. - PubMed
-
- Krupp LB, Serafin DJ, Christodoulou C. Multiple sclerosis-associated fatigue. Expert Rev Neurother 2010;10:1437–1447. - PubMed
-
- Feinstein A, Freeman J, Lo AC. Treatment of progressive multiple sclerosis: what works, what does not, and what is needed. Lancet Neurol 2015;14:194–207. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical